A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh
DiabCare Asia
2 other identifiers
observational
2,092
1 country
1
Brief Summary
This study is conducted in Asia. The aim of this non-interventional study is to evaluate the the current status of diabetes management, control, and complications in diabetic subjects with type 2 diabetes in Bangladesh.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 11, 2013
CompletedFirst Posted
Study publicly available on registry
June 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedJanuary 21, 2015
January 1, 2015
3 months
June 11, 2013
January 20, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients having HbA1c ((Glycosylated Haemoglobin) as measured during survey) less than 7%
Evaluated at the first visit (only one study visit)
Secondary Outcomes (8)
Mean Fasting Plasma Glucose (FPG) of patients
Evaluated at the first visit (only one study visit)
Mean Postprandial Plasma Glucose (PPG) of patients
Evaluated at the first visit (only one study visit)
Mean HbA1c of patients
Evaluated at the first visit (only one study visit)
Proportion of patients having dyslipidemia and hypertension
Evaluated at the first visit (only one study visit)
Proportion of patients having cardiovascular complications
Evaluated at the first visit (only one study visit)
- +3 more secondary outcomes
Study Arms (1)
Subjects with diabetes (type 2)
Interventions
Patients will fill out a questionnaire by interview.
Eligibility Criteria
People treated for at least a year are eligible for the study. The selection of the patients will be done randomly by the individual physician involved in the study.
You may qualify if:
- People with type 2 diabetes mellitus (DM) who are being treated, with any of the non-pharmacological or pharmacological options, at a particular centre for at least 1 year and who have visited the centre within the last 3-6 months
- Patients willing to sign informed consent form
You may not qualify if:
- Previous participation in this study
- Unable to comply with protocol requirements
- Confirmed or suspected pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (1)
Unknown Facility
Dhaka, 1206, Bangladesh
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2013
First Posted
June 13, 2013
Study Start
June 1, 2013
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
January 21, 2015
Record last verified: 2015-01